Status of ethics approval, anticipated start of the data collection, corona measures, corona contingency plan

Download

7 Downloads

Last Updated: 14-01-2021 8:42

DescriptionPreviewVersions

A status overview of the ethics approvals for the diisocyanates field studies is provided. Some challenges and contingencies in the recruitment phase are presented. Consequences of reduced response are presented using a power analysis. COVID19 infection of the study subject may have an impact on some of the measured parameters (inflammatory markers) . COVID19 vaccinations have started in different countries and are likely to continue until fall 2021. Also recent COVID19 vaccination may have an impact on these parameters.